Compliance to Guidelines in Prescribing Empirical Antibiotics for Individuals with Uncomplicated Urinary Tract Infection in a Primary Health Facility of Ghana, 2019-2021.
Ghana
West Africa
antimicrobial resistance
antimicrobial stewardship
audit-feedback mechanism
compliance
electronic medical records
operational research
sort it
urinary tract infections
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
29 09 2022
29 09 2022
Historique:
received:
02
08
2022
revised:
26
08
2022
accepted:
27
08
2022
entrez:
14
10
2022
pubmed:
15
10
2022
medline:
18
10
2022
Statut:
epublish
Résumé
Increasing trends in antimicrobial resistance among uropathogens call for rational use of empirical antibiotics for managing uncomplicated urinary tract infections (UTIs). In Ghana, standard treatment guidelines (STGs) for UTI recommend oral ciprofloxacin or cefuroxime for 5-7 days in females and 10-14 days in males. We conducted a cross-sectional audit using electronic medical records (EMR) to assess compliance to the STGs among adults (≥18 years) with uncomplicated UTIs diagnosed in a primary health facility between October 2019 and October 2021. Among 3717 patients, 71% were females and all had complete prescription details in the EMR. Of all the patients, 83% were prescribed empirical antibiotics, of whom 88% received oral ciprofloxacin or cefuroxime. Only 68% were prescribed antibiotics for the correct duration, which was significantly lower among males (10%) compared to females (90%). Among patients who received antibiotics, 60% were prescribed in line with the STGs. The results call for feedback to physicians about poor compliance to STGs with duration of antibiotic prescribed. Recommendations on 10-14 days duration of antibiotics for males needs to be reassessed and necessary amendments to STGs can be made. Leveraging the well-established EMR system, a real-time audit-feedback mechanism can be instituted to improve compliance with STGs.
Identifiants
pubmed: 36231716
pii: ijerph191912413
doi: 10.3390/ijerph191912413
pmc: PMC9566282
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Ciprofloxacin
5E8K9I0O4U
Cefuroxime
O1R9FJ93ED
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Department of Health
Pays : United Kingdom
Références
Curr Opin Infect Dis. 2016 Feb;29(1):73-9
pubmed: 26694621
Open Forum Infect Dis. 2019 May 06;6(6):ofz216
pubmed: 31249844
JAC Antimicrob Resist. 2021 Jun 14;3(2):dlab080
pubmed: 34223139
BMC Health Serv Res. 2021 Mar 24;21(1):272
pubmed: 33761948
Ann Intern Med. 2017 Oct 3;167(7):ITC49-ITC64
pubmed: 28973215
Am J Med. 2002 Jul 8;113 Suppl 1A:5S-13S
pubmed: 12113866
BMC Geriatr. 2021 Jul 23;21(1):436
pubmed: 34301192
Int J Infect Dis. 2021 Jan;102:497-500
pubmed: 33130204
BMC Infect Dis. 2021 Jun 29;21(1):619
pubmed: 34187385
Am J Obstet Gynecol. 2021 Nov;225(5):550.e1-550.e10
pubmed: 34418350
BMC Health Serv Res. 2018 Oct 16;18(1):777
pubmed: 30326891
BMJ. 2016 Mar 15;352:i939
pubmed: 26980184
Ann Intern Med. 2019 Aug 6;171(3):210-211
pubmed: 31284302
PLoS One. 2019 Mar 28;14(3):e0214572
pubmed: 30921411
Nat Rev Microbiol. 2015 May;13(5):269-84
pubmed: 25853778
Am J Obstet Gynecol. 2021 Sep;225(3):272.e1-272.e11
pubmed: 33848538
Int J Clin Pract. 2019 Oct 1;:e13427
pubmed: 31573741
JAC Antimicrob Resist. 2019 Nov 12;1(3):dlz072
pubmed: 34222945
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Int J Antimicrob Agents. 2017 Nov;50(5):629-639
pubmed: 28705671
Can J Infect Dis Med Microbiol. 2018 Feb 20;2018:7404095
pubmed: 29675117
BMJ. 2019 Feb 27;364:l440
pubmed: 30814052
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
JAMA Netw Open. 2022 May 2;5(5):e2214160
pubmed: 35616946
J Infect. 2009 Feb;58(2):91-102
pubmed: 19195714
JAMA. 2021 Jul 27;326(4):309-310
pubmed: 34313705
Open Forum Infect Dis. 2018 Aug 10;5(9):ofy198
pubmed: 30191156
JAC Antimicrob Resist. 2021 Feb 27;3(1):dlab003
pubmed: 34223081
J Glob Antimicrob Resist. 2021 Sep;26:148-153
pubmed: 34118479
Open Forum Infect Dis. 2015 Oct 26;2(4):ofv159
pubmed: 26753168
Infect Drug Resist. 2019 Jul 11;12:2059-2067
pubmed: 31372013
Clin Infect Dis. 2011 Mar 1;52(5):e103-20
pubmed: 21292654
Clin Infect Dis. 2021 Nov 16;73(10):1805-1812
pubmed: 33623985
Infect Dis Health. 2019 May;24(2):75-81
pubmed: 30598405
Glob Health Action. 2017;10(1):1289735
pubmed: 28485675
BMC Fam Pract. 2020 Jul 1;21(1):125
pubmed: 32611320
PLoS One. 2016 Nov 10;11(11):e0165151
pubmed: 27832082
Nat Rev Urol. 2010 Dec;7(12):653-60
pubmed: 21139641
PLoS One. 2020 Jun 4;15(6):e0231569
pubmed: 32497074
PLoS One. 2017 May 9;12(5):e0177266
pubmed: 28486532
Postgrad Med. 2020 Apr;132(3):234-250
pubmed: 31608743
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
BMJ Open. 2019 May 19;9(5):e027221
pubmed: 31110099
Health Econ Rev. 2019 Dec 29;9(1):39
pubmed: 31885056